“Yes Minister, we can deliver cheaper kidney care” Lisa Burnapp Lead Nurse-Living Donation, NHS Blood & Transplant Consultant Nurse-Living Donor Kidney.

Slides:



Advertisements
Similar presentations
Welcome to the new acute and community County Durham and Darlington NHS Foundation Trust Clinical strategy FT member events April 2011.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
Treatment Options for End Stage Kidney Disease Dr Vipula De Silva.
Medicare for People with End-Stage Renal Disease - Alaska Module 6: Version 12.
Basics of Organ Transplantation Lon Eskind, MD Director Liver Transplant, CMC Assoc. Medical Director of LifeShare.
Renal Replacement Therapy: What the PCP Needs to Know.
DIALYSIS OR TRANSPLANTATION Ahmed Halawa MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF.
KIDNEY FOUNDATION MISSION St. Gregorios Dayabhavan Kunigal.
Cheaper Kidney Care Vs. Redesigning kidney services to improve patient choice, shared decision making and deliver NHS costing savings.
CKD In Primary Care Dr Mohammed Javid.
18 week commissioning pathways for kidney disease and renal transplantation Specialty Clinical Leads Lawrence Goldberg: CKD and ESRF pathways John Scoble:
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Transition or transfer? Meeting the needs of young people Sue Dolby Consultant Clinical Psychologist Bristol Children’s Hospital.
Dr Judy Foster Chair St Michael’s Fellowship on the PMHCW Network Workshop E: Professional networks and their role in putting recommendations into practice.
Organ Donation & Transplantation in Ireland – Changing times Aileen Counihan Transplant Co-ordinator Beaumont Hospital Beaumont Hospital.
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
Living Donation Education For Kidney Patients, Their Family and Friends A Nonprofit Corporation Bryan Stewart Chief Executive Officer.
Feast or Famine: Survival and Chronic Kidney Disease Kerin Worley and Deb Gipson UNC Chapel Hill April, 2004.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
A single commissioning model for the organ donation and transplantation pathway – what are the pros and cons? Keith Rigg.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Kidney transplantation: why should I care? Staff Wellbeing Week Queen’s University Belfast 28 Jan 2015 Dr Aisling Courtney.
Specialised Commissioning of Kidney Transplantation Keith Rigg Chair, Renal Transplant CRG.
CKD: the primary/secondary care interface Daniel Ford Consultant Renal Physician UHCW.
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
Sandip Mitra Central Manchester University Hospitals Foundation Trust.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
Modernising Nursing Careers NMC Pre-registration Nursing Review Lesley Barrowman Workshop 26 th July 2007.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Vascular access The KidneyCare Audit. The challenge of vascular access – Renal National Service Framework Standard 3 “All children, young people and adults.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
Annual Informatics Meeting Changes to the Renal Registry Dataset Fiona Braddon Clinical Informatics Manager.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
Children and Young People Dr P J Carragher Chair of SLWG 6, L&DW.
Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information.
Renal Services Dr Donal O’Donoghue National Clinical Director for Kidney Care UKRR Annual Audit Meeting QEH Birmingham 30 September 2010 Working for Better.
Living Donor Kidney Transplantation 2020 Strategy Update Lisa Burnapp
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Survival after graft failure Dr Lynsey Webb Registrar UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
KIDNEY TRANSPLANTATION ULKEM CAKIR, MD PROFESSOR OF MEDICINE/NEPHROLOGY WOMEN IN KIDNEY TRANSPLANTATION 722 KIDNEY TX.
Graham Lipkin September 23 rd 2014 West Midlands Renal Network Transplant Education & Audit.
Obesity in kidney transplantation…. Dan Ridgway, Consultant Surgeon, Royal Liverpool University Hospital.
IMPROVING CONSENT VIA PATIENT SUPPORT GROUPS King Faisal Specialist Hospital & Research Center - Jeddah Yaser M Kattoah - Administrative Transplant Coordinator.
Access to renal transplantation Chris Dudley UKRR/UKT Joint analysis.
KIDNEY DONATION BY: TRICIA MONSON, BSN, RN KIMBERLY ALEXANDER, BA, BSN, RN KIMBERLY ALEXANDER, BA, BSN, RN.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Kidney disease burden and available Renal transplantation and Dialysis services in India Dr. Sham Sunder.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function R3 김동연 /Prof. 정경환 N Engl J Med 373;5 July 30, 2015.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Long Term Peritoneal Dialysis In Children – Frequent Complications Conclusions: Peritoneal Dialysis is the method of choice for pediatric patients, with.
Access to Transplantation in West Midlands The call for action Graham Lipkin Wmids Transplant First Event 16 th July 2015.
New kidney offering scheme … Lorna Marson Deputy Chair, Kidney Advisory Group Work in progress.
Living donation review Renal Transplant Services Meeting 17 March 2016 Aisling Courtney.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
Timely Listing West Midlands, July 2015 ‘Transplant First’ NHS Kidney Care NHS Blood and Transplant 2011/12 Lisa Burnapp Lead Nurse-Living Donation NHSBT.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
Kidney Transplant The Preferred Treatment for Most Patients with Kidney Failure Information for Patients July 2018.
KQuIP Transplant first- Living kidney donor transplantation
Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:  
Presentation transcript:

“Yes Minister, we can deliver cheaper kidney care” Lisa Burnapp Lead Nurse-Living Donation, NHS Blood & Transplant Consultant Nurse-Living Donor Kidney Transplantation, Guy’s & St. Thomas NHS Foundation Trust

Face the facts

We Know That…………………………. Quality of life of transplant recipients is significantly ↑ versus dialysis 1 Survival of transplant recipients is significantly ↑ versus wait-listed candidates on dialysis 2 The longer a patient is on dialysis prior to transplant, the poorer the transplant outcome 3 1 Evans RW, et al. New Engl J Med 1985;312:553–9; 2 Wolfe RA, et al. N Engl J Med 1999;341:1725–30; 3 Meier-Kriesche HU, et al. Kidney Int 2000;58:1311–17

We Know That…………………………… Transplantation facilitates Growth and development in children Return to the workforce Having a family Cost-effective for healthcare system

We Know That ………………………………… Survival Benefit of Kidney Transplantation Applies Across age groups Across disease groups Across racial groups Across countries Long-term dialysis patients Obese patients

We Know That…………………………… We have more Patients Choice & capability Expectation Complexity Ethnically diverse

1. Transplantation is Cheaper Than Dialysis Why?

1.Costs: Transplantation v Dialysis Transplantation Work-up & surgery – £ 21, st year post Tx – £ 19,000 Subsequent year – £ 2,400 Living Donor Work-up & nephrectomy – £5,500 Total (2yrs.) £ 48,650 Dialysis (per pt./p.a) Peritoneal Dx (APD) – £ 35,000 Centre/satellite HDx – £ 31,000 Peritoneal Dx (CAPD) – £ 27,350 Home HDx (excludes set up costs) – £20, 000

Our Responsibility To optimise Patient outcome Transplant outcome Planning Opportunity & choice Use of kidneys Donor safety & well-being The health economy

2. Living Donation is More Cost Effective than Deceased Donation Why?

Outcomes are Excellent Patient survival after LD transplantation 99% at 1 yr. (DD 96%) 95% at 5yrs. (DD 86%) Graft survival after LD transplantation 95% at 1 yr. (DD 92%) 88% at 5yrs. (DD 81%) *Data courtesy of NHSBT

3. Pre-emptive Living Donation is the Most Cost Effective Option Why?

Benefits of a Pre-Emptive Transplant Improved opportunity & choice Improved patient and graft survival Reduced dialysis-related morbidity Preservation of musculoskeletal integrity Reduced CV risk factors Preservation of employment and insurance Reduced cost

Hayes R, in Abecassis M, et al. Clin J Am Soc Nephrol 2008;3:471–80 Potential Pre-Emptive Transplant Advantages Valleys represent decreases in: Functional status, Self- esteem, Employability, Insurability, Quality of life Functional status Dialysis initiation Transplant Disease course Work status Family role Mental health Self care

Functional status Dialysis initiation Transplant Pre-emptive transplant Potential Pre-Emptive Transplant Advantages Disease course Work status Family role Mental health Self care Hayes R, in Abecassis M, et al. Clin J Am Soc Nephrol 2008;3:471–80

Treatment Cycle Patient

The Circuit Breaker Patient

Cost Comparison: 12 Months of HD before Transplant versus Pre-Emptive Kidney Transplant 34% reduction in costs at 2 years HD = haemodialysis; CKD = chronic kidney disease End stage renal diseaseCKD 15,000 10,000 5,000 0 – HD Kidney transplant Transplant maintenance 15,000 10,000 5,000 0 – Kidney transplant Transplant maintenance Months before and after first service date Cost ($) End stage renal diseaseCKD Cost ($) Schweitzer EJ, in Abecassis M, et al. Clin J Am Soc Nephrol 2008;3:471–80

Pre-emptive LD Transplant

4. Nationally, There are Inconsistencies in LD Activity Why?

Barriers Logistics Organisational – Infrastructure – Processes/pathways Clinical Philosophical ??

National Initiatives 2000 & 2005 – UK Guidelines for Living Kidney Donation (BTS/Renal Association) – 2005 – Renal National Service Framework 2006 – Human Tissue Act 2008 – 18 week commissioning pathway for living donor transplantation 2 1 United Kingdom Guidelines for Living Donor Kidney Transplantation Second Edition April

Donor Pool Previous legal framework 1 – Adult siblings – Parent to child – Adult child to parent – Grandparent – Extended family – Spouse/partner – Friend i.e. proven genetic/emotional relationship Current legal framework 2 – All of the above – ‘Children’ and adults lacking capacity* Plus – Paired/pooled donors – Altruistic/non-directed donors *Except Scotland 1 Human Organ Transplant Act Human Tissue Act 2004

UK Renal Registry 11 th Annual Report 2008

5. We Need to Think Differently? How?

Pre-emptive Living Donor Transplants (% total)* *Data courtesy of UK Transplant

Historical Approach eGFR = estimated glomerular filtration rate (mL/min/1.73m 2 )

New Approach eGFR≈20 Living donor assessment Living donor transplant Vascular access Peritoneal dialysisHaemodialysis Deceased donor listing eGFR = estimated glomerular filtration rate (mL/min/1.73m 2 )

Acknowledgements: Contributors to slide set GSTT Dr. John Scoble NHSBT Rachel Johnson